VEGF therapy: a timely retreat

Cardiovasc Res. 2009 Sep 1;83(4):611-2. doi: 10.1093/cvr/cvp228. Epub 2009 Jul 3.
No abstract available

Publication types

  • Comment
  • Editorial

MeSH terms

  • Animals
  • Dependovirus / genetics
  • Doxycycline / administration & dosage
  • Gene Expression / drug effects
  • Humans
  • Ischemia / therapy
  • Neovascularization, Physiologic / drug effects
  • Recombinant Proteins / genetics
  • Recombinant Proteins / therapeutic use
  • Vascular Endothelial Growth Factor A / genetics*
  • Vascular Endothelial Growth Factor A / therapeutic use*

Substances

  • Recombinant Proteins
  • Vascular Endothelial Growth Factor A
  • Doxycycline